Sujay Kumar Singh

Sujay Kumar Singh

Active Director Director DIN 00616056
DIN 00616056 First appointment Nov 2002 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Nov 2002
Shareholding value •••• Premium profile

About Sujay Kumar Singh

Data last updated:

Sujay Kumar Singh is a Director at Imgenex India Private Limited (since 2004), Director at Abgenex Private Limited (since 2002) and Director at Bio Entities Private Limited (since 2009). The companies operate in Life Sciences, Research & Development and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹5.93 Cr; the largest is Imgenex India Private Limited at ₹4.32 Cr (FY 2025). Earlier, Sujay Kumar Singh was a Director at Samik Pharmaceuticals Private Limited (2011–2024) and Director at Charak International Private Limited (from 2007).

DIN 00616056
Primary Designation Director
Industry Life Sciences
First Appointment 25 Nov 2002
Oldest Company Age 23 yrs
Largest company Imgenex India Private Limited · ₹4.32 Cr (FY 2025)
Combined revenue ₹5.93 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Imgenex India Private Limited U24239OR2004PTC007628
Director04 Jun 20042004₹4.32 Cr (FY 2025)Active
Abgenex Private Limited U24239OR2002PTC006982
Director25 Nov 20022002₹1.35 Cr (FY 2025)Active
Bio Entities Private Limited U72100OR2009PTC011316
Director13 Nov 20092009₹25.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Sep 20112011Strike Off
Charak International Private Limited U24231OR2007PTC009349
Director11 Jun 20072007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Charak International Private Limited
Abgenex Private Limited
Imgenex India Private Limited
Bio Entities Private Limited
Premium access

Shareholding and investment profile for Sujay Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sujay Kumar Singh

Sujay Kumar Singh currently holds 3 directorships: Imgenex India Private Limited (Director, since 04 Jun 2004, revenue ₹4.32 Cr (FY 2025)); Abgenex Private Limited (Director, since 25 Nov 2002, revenue ₹1.35 Cr (FY 2025)); Bio Entities Private Limited (Director, since 13 Nov 2009, revenue ₹25.3 Lakh (FY 2025)).

Sujay Kumar Singh was first appointed on 25 Nov 2002 as Director at Abgenex Private Limited. The most recent appointment on record is 23 Sep 2011 at Samik Pharmaceuticals Private Limited.

The 3 current companies of Sujay Kumar Singh that report revenue have a combined latest revenue of ₹5.93 Cr: Imgenex India Private Limited ₹4.32 Cr (FY 2025); Abgenex Private Limited ₹1.35 Cr (FY 2025); Bio Entities Private Limited ₹25.3 Lakh (FY 2025).

Sujay Kumar Singh held 2 earlier board appointments: Samik Pharmaceuticals Private Limited (Director, 23 Sep 2011 to 24 Jan 2024); Charak International Private Limited (Director, from 11 Jun 2007).

The current boards of Sujay Kumar Singh's companies include Gita Singh (Imgenex India Private Limited), Prasanta Kumar Maiti (Imgenex India Private Limited), Subrat Kumar Kar (Imgenex India Private Limited), Jabed Akhtar (Abgenex Private Limited), Saroj Kumar Sahu (Bio Entities Private Limited), Sujita Brahma (Bio Entities Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available